Lunger John - Insider Non-Derivative Transactions at Adaptimmune Therapeutics PLC (ADAP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 17, 2024, Lunger John's relationship to Adaptimmune Therapeutics PLC (ADAP) is Officer (Chief Patient Supply Officer), and currently has 19,015 shares of American Depositary Shares representing Ordinary Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ADAP insiders.

Data Source: SEC.
Lunger John - Insider Non-Derivative Transactions of ADAP American Depositary Shares representing Ordinary Shares
Lunger John - Insider Non-Derivative Transactions at ADAP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 18, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 5309 0.67 7785
Jan 18, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 12805 0.67 19015
Jan 17, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 4681 0.79 7023
Jan 13, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 5220 0.85 7874
Jan 12, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 4009 0.84 6104
Aug 2, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 3096 0.91 4718
Jan 18, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 4440 1.86 7264
Jan 13, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 4973 1.71 8121
Jan 12, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 3843 1.75 6270
Jan 5, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 1100 1.69 1725